Theragen Etex Co.,Ltd. (KOSDAQ:066700)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,515.00
-75.00 (-2.90%)
At close: Mar 9, 2026
-18.61%
Market Cap 92.26B
Revenue (ttm) 268.13B
Net Income (ttm) -46.45B
Shares Out 36.68M
EPS (ttm) -1,244.95
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 77,208
Average Volume 128,020
Open 2,550.00
Previous Close 2,590.00
Day's Range 2,465.00 - 2,550.00
52-Week Range 2,370.00 - 3,470.00
Beta 0.20
RSI 31.82
Earnings Date Mar 19, 2026

About Theragen Etex

Theragen Etex Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products in Korea. It offers drugs in the fields of circulatory, respiratory, digestive, antibiotics, antifungals, analgesic, endocrine and metabolic, hepatoprotective, psychotropic, urinary system, skeletal muscle, PMS, anthelmintic, nutrition, and others. The company was formerly known as Theragen Co., Ltd. and changed its name to Theragen Etex Co.,Ltd. in July 2010. Theragen Etex Co.,Ltd. was founded in 1987... [Read more]

Industry Special Industry Machinery, not elsewhere classified
Founded 1987
Employees 224
Stock Exchange KOSDAQ
Ticker Symbol 066700
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.